NMPA Product

Gliclazide Modified Release Tablets

Product approved by National Medical Products Administration (CN)

Basic Information

Product Name

Gliclazide Modified Release Tablets

Generic Name

格列齐特缓释片

Strength

30mg

Dosage Form

片剂

Regulatory Information

Approval Number

国药准字H20233537

Approval StatusApproved

Drug Type

化学药品

Approval Date

May 12, 2023

Company Information

Manufacturer华润双鹤利民药业（济南）有限公司

Production Company华润双鹤利民药业（济南）有限公司

Active Ingredients

Gliclazide Sustained-release Tablets

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy